Literature DB >> 15000751

Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells.

Qiuhong Xie1, Shigeru Matsunaga, Setsuko Niimi, Setsuko Ogawa, Ken Tokuyasu, Yoshikiyo Sakakibara, Sachiko Machida.   

Abstract

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a unique scavenger receptor that plays important roles in atherogenesis and has been thought to function as a monomer. Using coimmunoprecipitation studies, we demonstrate that human LOX-1 (hLOX-1) forms constitutive homo-interactions in vivo. Western blot analysis of cell lysates under nonreducing or reducing conditions revealed one clear immunoreactive species corresponding to the size of a putative receptor dimer or a monomer, respectively, consistent with the presence of disulfide-linked hLOX-1 complexes. Site-directed mutagenesis studies indicated that cysteine 140 has a key role in the formation of these disulfide-linked hLOX-1 dimers. Eliminating this intermolecular disulfide bond markedly impairs the recognition of Escherichia coli by hLOX-1. Furthermore, these dimers can act as a "structural unit" to form noncovalently associated oligomers, as demonstrated by a membrane-impermeant crosslinker, which resulted in immunoreactive species corresponding to the sizes of putative tetramers and hexamers. These results provide the first evidence for the existence of hLOX-1 dimers/oligomers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000751     DOI: 10.1089/104454904322759920

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  7 in total

1.  Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer.

Authors:  Magomed Khaidakov; Sona Mitra; Bum-Yong Kang; Xianwei Wang; Susan Kadlubar; Giuseppe Novelli; Vinay Raj; Maria Winters; Weleetka C Carter; Jawahar L Mehta
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

Review 2.  Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use.

Authors:  Joaquim Barreto; Sotirios K Karathanasis; Alan Remaley; Andrei C Sposito
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-12       Impact factor: 10.514

3.  Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer.

Authors:  Long Jiang; Shanshan Jiang; Yongbin Lin; Han Yang; Zerui Zhao; Zehua Xie; Yaobin Lin; Hao Long
Journal:  Oncotarget       Date:  2015-09-08

Review 4.  LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.

Authors:  Barbara Rizzacasa; Elena Morini; Sabina Pucci; Michela Murdocca; Giuseppe Novelli; Francesca Amati
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

5.  Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset.

Authors:  Carmine Di Rienzo; Emanuela Jacchetti; Francesco Cardarelli; Ranieri Bizzarri; Fabio Beltram; Marco Cecchini
Journal:  Sci Rep       Date:  2013-01-25       Impact factor: 4.379

6.  Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant.

Authors:  Mattia Falconi; Silvia Biocca; Giuseppe Novelli; Alessandro Desideri
Journal:  BMC Struct Biol       Date:  2007-11-07

7.  Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein.

Authors:  Shraddha Thakkar; Xianwei Wang; Magomed Khaidakov; Yao Dai; Kuppan Gokulan; Jawahar L Mehta; Kottayil I Varughese
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.